Bolt BiotherapeuticsBOLT
13F holders, Q3 2025 (September 30)At the end of Q3 2025, 24 institutions reported holding Bolt Biotherapeutics Inc. (BOLT) in their 13F filings, down 1 from Q2 2025. 3 opened new positions and 4 sold out. The largest holders were Vivo Capital, LLC ($937K), Sofinnova Investments, Inc. ($733K) and Pivotal bioVenture Partners Investment Advisor LLC ($503K). One famous investor held it Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Bolt Biotherapeutics Inc.
- CUSIP
- 097702203
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $239K |
| Exits | 4 | $66K |
All 13F filers, Q2 2025 → Q3 2025: 57,670 shares bought and 141,165 shares sold, net −83,495 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 24 holders
| Vivo Capital, LLC | 0.08% | No change | 176,064 | $937K |
| Sofinnova Investments, Inc. | 0.04% | No change | 137,721 | $733K |
| Pivotal bioVenture Partners Investment Advisor LLC | 0.29% | No change | 94,573 | $503K |
| Tang Capital Management LLC | 0.01% | Reduce -59.9% | 66,879 | $356K |
| Nan Fung Group Holdings Ltd | 0.52% | No change | 58,347 | $310K |
| Samsara Biocapital, LLC | 0.03% | Reduce -6.9% | 48,830 | $260K |
| Board of Trustees of The Leland Stanford Junior University | 0.02% | No change | 35,978 | $191K |
| Vanguard Group Inc. | 0.00% | Reduce -41.5% | 34,231 | $182K |
| Pfizer Inc | 0.04% | No change | 31,305 | $167K |
| Renaissance Technologies | 0.00% | Add +56.2% | 28,625 | $152K |
| Geode Capital Management, LLC | 0.00% | No change | 18,533 | $99K |
| Susquehanna International Group, LLP | 0.00% | New | 16,642 | $89K |
| Shay Capital LLC | 0.02% | New | 15,958 | $85K |
| Squarepoint Ops LLC | 0.00% | Add +19.8% | 14,836 | $79K |
| DRW Securities, LLC | 0.00% | New | 12,322 | $66K |
| BlackRock, Inc. | 0.00% | Reduce -8.0% | 9,711 | $52K |
| Morgan Stanley | 0.00% | Reduce -12.6% | 3,128 | $17K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -34.4% | 259 | $1K |
| JPMorgan Chase & Co. | 0.00% | Reduce -2.3% | 42 | $223 |
| Bank of America Corp. | 0.00% | Reduce -89.0% | 31 | $165 |
| SBI Securities Co., Ltd. | 0.00% | No change | 10 | $53 |
| Barclays PLC | 0.00% | No change | 6 | $32 |
| UBS Group AG | 0.00% | Reduce -98.4% | 3 | $16 |
| Salem Investment Counselors Inc. | 0.00% | No change | 2 | $11 |
"% of holder's portfolio" is BOLT's weight in each manager's 13F, not the share of Bolt Biotherapeutics Inc. the manager owns.